-
Ligand Pharmaceuticals (NASDAQ:LGND) Rating Increased to Hold at StockNews.com
Source: Buzz FX / 18 Mar 2025 01:26:15 America/Chicago
Ligand Pharmaceuticals (NASDAQ:LGND) Rating Increased to Hold at StockNews.com Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) was upgraded by equities
Read more...